Loading...
A Current Perspective on Daptomycin for the Clinical Microbiologist
SUMMARY: Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-positive bacteria that was first approved for clinical use in 2004 in the United States. Since this time, significant data have emerged regarding the use of daptomycin for the treatment of serious inf...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3811228/ https://ncbi.nlm.nih.gov/pubmed/24092854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CMR.00030-13 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|